NASDAQ:AUPH
Aurinia Pharmaceuticals Inc Stock News
$5.21
-0.0300 (-0.573%)
At Close: May 24, 2024
Expert Ratings For Aurinia Pharmaceuticals
06:23pm, Friday, 10'th Dec 2021 Business Insider Markets
Within the last quarter, Aurinia Pharmaceuticals (NASDAQ: AUPH ) has observed the following analyst
Aurinia Pharma upgraded at Oppenheimer; ongoing M&A story noted
01:23pm, Friday, 10'th Dec 2021 Seeking AlphaPleasing stocks: Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH 0.67%), Walmart Inc. (NYSE:WMT 0.98%)
11:51pm, Thursday, 09'th Dec 2021 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Pleasing stocks: Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH 0.67%), Walmart Inc. (NYSE:WMT 0.98%) appeared first on Stocks Equity .
Aurinia Pharmaceuticals nearing highs on report about M&A process
06:25pm, Thursday, 09'th Dec 2021 Seeking AlphaThe 2 Nasdaq Biotech Stocks to Watch Thursday
02:00pm, Thursday, 09'th Dec 2021 The Motley Fool
The market is getting close to new highs again, but choppy performance is likely.
Thinking about buying stock in Ensysce Biosciences, Siyata Mobile, Evgo, Aurinia Pharmaceuticals, or Hall of Fame Resort & Entertainment?
01:30pm, Thursday, 09'th Dec 2021 PR Newswire
NEW YORK, Dec. 9, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ENSC, SYTA, EVGO, AUPH, and HOFV. To see how InvestorsObserver''s proprietary scoring system rates these stocks, view the InvestorsObserver''s PriceWatch Alert by selecting the corresponding link.
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
12:47pm, Thursday, 09'th Dec 2021 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug
Reata Pharmaceuticals, Inc.
Biotech Stock Boosted on Late-Stage Trial Data
11:16am, Thursday, 09'th Dec 2021
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is up 4.8% to trade at $21.83, after a late-stage trial of the company's treatment for active lupus nephritis showed sustained efficacy and a favorable ris
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)
11:15am, Thursday, 09'th Dec 2021 Business Wire
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today announced positive topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of LUPKYNIS (voclosporin) for the treatment of adults with active lupus nephritis (LN), a serious complication in patients with systemic lupus ery
Aurinia's Voclosporin Shows favorable Risk/Benefit Profile Over 3 Years In Lupus Nephritis
09:37am, Thursday, 09'th Dec 2021
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has posted topline results from the AURORA 2 continuation study evaluating the long-term safety and tolerability of Lupkynis (voclosporin) for active lupu
Aurinia Pharmaceuticals Stock (AUPH): Why The Price Increased Today
09:19am, Thursday, 09'th Dec 2021
The stock price of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) increased by over 3% pre-market today. This is why it happened.
8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022
03:00pm, Tuesday, 07'th Dec 2021 The Motley Fool
These eight stocks could rebound nicely over the next year and beyond.
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Given Consensus Rating of Hold by Analysts
09:14am, Tuesday, 07'th Dec 2021 Dakota Financial News
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSE:AUP) has earned a consensus recommendation of Hold from the seven ratings firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and four have issued a buy recommendation on the company. The average 1 year []
Traders cant mares this Stock: Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), BrightSphere Investment Group Inc. (NYSE:BSIG)
09:48am, Saturday, 04'th Dec 2021 Stock Equity
Aurinia Pharmaceuticals Inc. (AUPH) with the stream of -7.30% also noticed, India BrightSphere Investment Group Inc. (BSIG) encountered a rapid change of -9.50% in the last hour of Fridays trading The post Traders cant mares this Stock: Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), BrightSphere Investment Group Inc. (NYSE:BSIG) appeared first on Stocks Equity .
Aurinia (AUPH) Stock Up on Potential Acquisition Rumors
03:11pm, Friday, 03'rd Dec 2021 Zacks Investment Research
Aurinia (AUPH) gains on rumors of a potential acquisition yet again. Reportedly, the company is being eyed by Novartis.